Catalyst Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Catalyst Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $0.57 | $0.30 | 90.0 % |
Jun 2024 | 2024-08-07 | $0.56 | $0.26 | 115.4 % |
Mar 2024 | 2024-05-08 | $0.38 | $0.17 | 123.5 % |
Dec 2023 | 2024-02-28 | $0.53 | $0.26 | 103.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $128.70M | $123.42M | 4.27 % |
Jun 2024 | 2024-08-07 | $122.71M | $111.96M | 9.60 % |
Mar 2024 | 2024-05-08 | $98.51M | $98.13M | 0.39 % |
Sep 2023 | 2023-11-08 | $102.69M | $100.38M | 2.30 % |
Catalyst Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3.
Catalyst Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was $0.57, which beat the estimate of $0.30.
Catalyst Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.